| For: | Li CB, Ning YT, Shen NY, Wang B, Xiao H, Luo G. Systemic treatment of liver cancer: Current status and future perspectives. World J Hepatol 2025; 17(7): 107520 [PMID: 40747233 DOI: 10.4254/wjh.v17.i7.107520] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v17/i7/107520.htm |
| Number | Citing Articles |
| 1 |
Jintao Zheng, Guoqiang Cao, Jialing Zhao, Longjie Yu, Xiujin Ye, Junru Chen, Haiyang Xie, Jianhui Li, Changku Jia. Prognostic value of PRAME gene promoter methylation and expression in hepatocellular carcinoma. Clinical Epigenetics 2026; 18(1) doi: 10.1186/s13148-026-02152-7
|
| 2 |
Thi Tuyet Mai Nguyen, Cam Phuong Pham, Minh Phuong Vu. Neutrophil‑to‑lymphocyte ratio as a predictive marker for portal vein thrombosis in hepatocellular carcinoma. World Academy of Sciences Journal 2026; 8(3) doi: 10.3892/wasj.2026.459
|
| 3 |
Chenlu Qian, Yan Wu, Chuan Yin, Jie Gao. Progress in hepatoprotective strategies during TACE treatment. Advanced Interventional Materials 2026; 1(1) doi: 10.1016/j.advim.2026.100012
|
| 4 |
Huijie Zhang, Shiying Li, Ruixuan Cui, Xin He, Sijie Liu, Fanxi Yin, Yan Zhang. Glycyrrhetinic Acid-Grafted Glycogen Nanoparticles Mediated Hepatic Delivery of Survivin Antisense Oligonucleotides for Liver Cancer-Targeted Gene Therapy. ACS Omega 2026; 11(25) doi: 10.1021/acsomega.6c01297
|
| 5 |
Tanvi Desai, Ekta Rawat, Nitin G. Haswani, Shadma Wahab, Saad Ali Alshehri, Devesh U. Kapoor. Alginate-driven nanotherapeutics in liver cancer: design, applications, and future perspectives. International Journal of Pharmaceutics 2026; 696 doi: 10.1016/j.ijpharm.2026.126844
|